Part -a |
|
|
|
|
|
Date |
Particulars |
|
Amount($) |
|
Amount($) |
20.10.2018 |
Redeemable Preference Share Capital A/c |
Dr. |
1,20,000 |
|
|
|
Premium on Redemption of Preference Shares |
Dr. |
6,000 |
|
|
|
Preference Shareholders A/c |
|
|
Cr. |
1,26,000 |
|
(Redemption amount of preference shares |
|
|
|
|
|
payable to preference shareholders) |
|
|
|
|
20.10.2018 |
Retained Earnings A/c |
Dr. |
1,26,000 |
|
|
|
Capital Redemption Reserve A/c |
|
|
Cr. |
1,26,000 |
|
(Provision made for redemption from retained |
|
|
|
|
|
earnings) |
|
|
|
|
25.10.2018 |
Preference Shareholders A/c |
Dr. |
1,26,000 |
|
|
|
Bank A/c |
|
|
Cr. |
1,26,000 |
30.11.2018 |
Cash A/c |
Dr. |
1,94,560 |
|
|
|
Receivable- Underwriter |
Dr. |
48,640 |
|
|
|
Share Capital-Ordinary Class 1 |
|
|
Cr. |
2,43,200 |
|
(Issue of 51200 right shares @ 3.80 $ each and |
|
|
|
|
|
the balance shares underwritten by Underwriter) |
|
|
|
|
Note : |
1 for 5 shares were to be issued . |
|
|
|
|
|
hence no of shares issued = 320000*1/5= 64000 |
|
|
|
|
|
shares availed= 256000*1/5= 51200 shares only |
|
|
|
|
|
|
|
|
|
|
20.12.2018 |
Receivable -undewriter |
Dr. |
4,800 |
|
|
|
Cash |
|
|
Cr. |
4,800 |
|
(Underwriting Costs paid) |
|
|
|
|
10.01.2019 |
Retained Earnings |
Dr. |
56,000 |
|
|
|
General Reserve A/c |
|
|
Cr. |
56,000 |
|
(amount transferred from retained earnings to |
|
|
|
|
|
General Reserve A/c) |
|
|
|
|
28.02.2019 |
Cash A/c |
Dr. |
2,01,600 |
|
|
|
Share Capital- Ordinary Class 3 |
|
|
Cr. |
2,01,600 |
|
(56000 shares issued against the options |
|
|
|
|
|
exercised- @ 3.60 $ per share) |
|
|
|
|
31.05.2019 |
Bank A/c (228000 shares @ $ 1.60) |
Dr |
3,64,800 |
|
|
|
Calls in Arrear (12000 shares @ $1.60) |
Dr |
19,200 |
|
|
|
Share Allotment A/c |
|
|
Cr |
3,84,000 |
|
(allotment money received except for 12000 shares) |
|
|
|
|
18.06.2019 |
Share Capital A/c (12000 shares @ $4) |
Dr |
48,000 |
|
|
|
Final Call on Shares (12000 shares @ $ 1.6) |
|
|
Cr |
19,200 |
|
Share Forfeiture A/c (12000 shares @ $ 2.4) |
|
|
Cr |
28,800 |
|
(being 12000 shares forfeited for non payment |
|
|
|
|
|
of final call) |
|
|
|
|
26.06.2019 |
Cash A/c (12000 * 3.60 $) |
Dr. |
43,200 |
|
|
|
Share Forfeiture A/c (12000* $ 0.40) |
Dr. |
4,800 |
|
|
|
Share Capital A/c |
|
|
Cr. |
48,000 |
|
(Re-issue of forfeited shares ) |
|
|
|
|
26.06.2019 |
Share Forfeiture A/c |
Dr. |
24,000 |
|
|
|
Payable to Shareholders of forfeited shares |
|
|
Cr |
24,000 |
|
(balance remaining in share forfeiture a/c to |
|
|
|
|
|
be paid to former holders of forfeited shares) |
|
|
|
|
|
($ 28800- $ 4800) |
|
|
|
|
27.06.2019 |
Payable to Shareholders of forfeited shares |
Dr |
24,000 |
|
|
|
Bank/ Cash A/c |
|
|
Cr |
24,000 |
|
(amount paid) |
|
|
|
|
Equity section of ChiHerbal’s statement of Financial Position as at 30th june 2019 |
|
||
Particulars |
|
|
Amount ($) |
Ordinary Class 1 Shares |
|
|
|
|
320000 shares @ $ 4 fully paid |
12,80,000 |
|
|
51200 shares @ 3.80 $ fully paid |
1,94,560 |
14,74,560 |
Ordinary Class 2 Shares |
|
|
|
|
228000 shares @ $ 4 fully paid |
|
9,12,000 |
Ordinary Class 3 Shares |
|
|
|
|
12000 shares @ $ 4 fully paid |
|
48,000 |
Retained Earnings |
|
4,52,800 |
|
General Reserve |
|
56,000 |
Part -a |
|
|
|
|
Journal Entries for Revaluation of Assets : |
|
|
|
|
The values of assets as at 30th June 2018 are given. Also the balances on this date for Revaluation |
||||
Surplus A/c are given . |
|
|
|
|
Date |
Particulars |
|
Amount($) |
Amount($) |
30.06.2018 |
Residential Land A/c |
Dr. |
1,60,000 |
|
|
Revaluation Surplus A/c |
|
|
1,60,000 |
|
(being land value increased due to revaluation |
|
|
|
|
and the increment of value credited to |
|
|
|
|
revaluation surplus a/c ) |
|
|
|
30.06.2018 |
Revaluation Surplus A/c |
Dr. |
3,20,000 |
|
|
Factory Land A/c |
|
|
3,20,000 |
|
(being land value decreased due to revaluation |
|
|
|
|
and the downfall in value debited to |
|
|
|
|
revaluation surplus a/c ) |
|
|
|
30.06.2018 |
Building A/c |
Dr. |
3,20,000 |
|
|
Revaluation Surplus A/c |
|
|
3,20,000 |
|
(being building value increased due to revaluation |
|
|
|
|
and the increment of value credited to |
|
|
|
|
revaluation surplus a/c ) |
|
|
|
|
Calculation of Carrying Amount of Building |
|
|
|
|
Building at valuation 2014 |
|
12,80,000 |
|
|
Less : Accumulated Depreciation |
|
1,60,000 |
|
|
Carrying Amount of Building |
|
11,20,000 |
|
|
New Fair Value |
|
14,40,000 |
|
|
Transfer to Revaluation Surplus |
|
3,20,000 |
|
Part -b |
|
|
|
|
Date |
Particulars |
|
Amount($) |
Amount($) |
01.07.2017 |
Truck A/c |
Dr. |
57,142 |
|
|
Revaluation Surplus A/c |
|
|
57,142 |
|
(Difference between the Carrying Amount of |
|
|
|
|
Truck and Fair Value transferred to respective |
|
|
|
|
accounts) |
|
|
|
01.07.2018 |
Disposal of Assets A/c |
Dr. |
3,33,333 |
|
|
Truck A/c |
|
|
3,33,333 |
|
(carrying value of truck transferred to disposal |
|
|
|
|
account) |
|
|
|
01.07.2018 |
Bank A/c or Cash A/c |
Dr. |
2,20,000 |
|
|
Disposal of Assets A/c |
|
|
2,20,000 |
|
(amount received transferred to disposal a/c) |
|
|
|
01.07.2018 |
Income Statement |
Dr. |
1,13,333 |
|
|
Disposal of Assets A/c |
|
|
1,13,333 |
|
(loss arising due to difference in carrying value |
|
|
|
|
and sales proceeds transferred to Income |
|
|
|
|
statement) |
|
|
|
01.07.2018 |
Revaluation Surplus A/c |
Dr. |
57,142 |
|
|
Retained Earnings |
|
|
57,142 |
|
(balance of revalued surplus transferred to |
|
|
|
|
Retained Earnings) |
|
|
|
Working Notes : |
|
|
|
|
Note -1 |
|
|
|
|
Purchase Value of Truck as on 01st July 2015 |
$ |
4,80,000 |
|
|
Depreciation using Straight Line Method |
|
|
|
|
(Value of truck- estimated residual value) |
|
|
|
|
Expected Life Years |
|
|
|
|
($ 480000- Nil)/ 7 |
$ |
68,571 |
|
|
Depreciation for 2nd year |
$ |
68,571 |
|
|
Carrying Amount of Truck as on 1st July 2017 |
$ |
3,42,858 |
|
|
Note -2 |
|
|
|
|
New Fair Value of Truck as on 1st July 2017 |
$ |
4,00,000 |
|
|
Depreciation using Straight Line Method |
|
|
|
|
(Value of truck- estimated residual value) |
|
|
|
|
Expected Life Years |
|
|
|
|
($ 400000- Nil)/ 6 |
$ |
66,667 |
|
|
Carrying Amount of Truck as on 1st July 2018 |
$ |
3,33,333 |
|
As nothing is specified in the question we are assuming the lease to be finance lease. |
|
||
Also, the lease term is equal to the useful life, it can be considered as financial lease |
|
||
Journal entries in books of lessor Easy Rental Ltd. |
|
|
|
Date |
Particulars |
Amount($) |
Amount($) |
01.07.2018 |
Lease Receivable |
1,04,526 |
|
|
Motor Vehicle |
|
1,04,526 |
|
(Present Value of Lease Rentals of Six Years |
|
|
|
-Working Note-1) |
|
|
Year 2019 |
Cash |
24,000 |
|
|
Lease Receivable ($ 24000- $ 2400) |
|
21,600 |
|
Finance Income ($ 24000 *10%) |
|
2,400 |
|
(Instalment received for 1st year) |
|
|
|
**Finance Income is 10% of the yearly lease rent |
|
|
Year 2020 |
Cash |
24,000 |
|
|
Lease Receivable ($ 24000- $ 2160) |
|
21,840 |
|
Finance Income ($ 21600 *10%) |
|
2,160 |
|
(Instalment received for 2nd year) |
|
|
|
** Finance Income will now be calculated on reduced |
|
|
|
Lease Receivable |
|
|
Working Note -1 |
|
|
|
Present Value of Lease Rentals of 6 years: |
|
|
|
Year |
Lease Rentals |
PV factor |
|
|
|
@ 10% |
|
1 |
24,000 |
0.909 |
21,818 |
2 |
24,000 |
0.826 |
19,835 |
3 |
24,000 |
0.751 |
18,032 |
4 |
24,000 |
0.683 |
16,392 |
5 |
24,000 |
0.621 |
14,902 |
6 |
24,000 |
0.564 |
13,547 |
|
|
|
|
There is zero unguaranteed residual value. |
|
|
Journal entries in books of lessee ChiHerbal Ltd. |
|
|
|
|
|
In case of finance lease, the lessee records both asset and liablity at the inception of lease tenure |
|||||
of an amount equal to present value of lease rentals |
|
|
|
|
|
Date |
Particulars |
|
Amount($) |
|
Amount($) |
01.07.2018 |
Lease Asset |
Dr. |
1,04,526 |
|
|
|
Lease Liability |
|
|
Cr. |
1,04,526 |
|
(Present Value of Lease Rentals of Six Years |
|
|
|
|
|
-Working Note-1) |
|
|
|
|
Year 2019 |
Lease Liability ($ 24000- $ 2400) |
Dr. |
21,600 |
|
|
|
Interest Expense ($ 24000 *10%) |
Dr. |
2,400 |
|
|
|
Cash |
|
|
Cr. |
24,000 |
|
(Instalment paid for 1st year) |
|
|
|
|
|
**Interest Expense is 10% of the yearly lease rent |
|
|
|
|
Year 2020 |
Lease Liability ($ 24000- $ 2160) |
Dr. |
21,840 |
|
|
|
Interest Expense ($ 21600 *10%) |
Dr. |
2,160 |
|
|
|
Cash |
|
|
Cr. |
24,000 |
|
(Instalment paid for 2nd year) |
|
|
|
|
|
** Interest expense will now be calculated on reduced |
|
|
||
|
Lease Liability |
|
|
|
|
Entry of Depreciation is also done in books of lessee. The rate is not given |
|
|
|||
Entry is: |
Depreciation A/c |
Dr. |
|
|
|
|
Lease Asset A/c |
Cr. |
|
|
|
As per AASB 138, an intangible asset must be measured at cost which includes purchase price and all |
|||||
the directly attributable costs for preparing of the assets for its use. |
|
|
|
||
in the given question, the asset is an internally generated intangible asset which is developed in ‘ |
|||||
2 phases- the research phase and the development phase |
|
|
|
|
|
Journal Entries |
|
|
|
|
|
Date |
Particulars |
|
Amount($) |
|
Amount($) |
For Expense on Product Research |
|
|
|
|
|
|
Product Development Cost |
Dr. |
3,50,000 |
|
|
|
Bank A/c |
|
|
Cr. |
3,50,000 |
|
(The cost has been capitalised as it is assumed to |
|
|
|
|
|
create future economic benefits) |
|
|
|
|
For Expense on Prototype development |
|
|
|
|
|
|
Prototype Development Cost |
Dr. |
5,28,000 |
|
|
|
Bank A/c |
|
|
Cr. |
5,28,000 |
|
(The cost has been capitalised as it is assumed to |
|
|
|
|
|
create future economic benefits) |
|
|
|
|
For Expense on Legal Cost of Patent |
|
|
|
|
|
|
Patent Cost |
Dr. |
22,000 |
|
|
|
Bank A/c |
|
|
Cr. |
22,000 |
|
(The cost has been capitalised as it is assumed to |
|
|
|
|
|
create future economic benefits and it has a long |
|
|
|
|
|
life of 4 years) |
|
|
|
|
For Expense on Marketing Campaign |
|
|
|
|
|
|
Cost on Marketing Cost |
Dr. |
6,50,000 |
|
|
|
Bank A/c |
|
|
Cr. |
6,50,000 |
|
(This cost shall be treated as a revenue expenditure |
|
|
|
|
|
as marketing shall continue even after the product |
|
|
|
|
|
has started genearted revenues) |
|
|
|
|
For Recognition of Sales Revenue at present value |
|
|
|
|
|
|
Amount Receivable |
Dr. |
150,00,000 |
|
|
|
Sales A/c |
|
|
Cr. |
150,00,000 |
|
(being amount of sales booked at present value) |
|
|
|
|
Total Cost of Intangible asset |
|
|
|
|
|
Research Cost |
|
3,50,000.00 |
|
|
|
Protype Cost |
|
|
5,28,000.00 |
|
|
Legal Cost |
|
|
22,000.00 |
|
|
Total Cost of Intangible Asset |
|
9,00,000.00 |
|
|
|
For Amortization Expenses |
|
|
|
|
|
|
Amortization expenses |
Dr. |
2,25,000 |
|
|
|
Intangible Asset |
|
|
Cr. |
2,25,000 |
|
( Being Asset amortized over period of 4 years i.e 900000/4) |
|
|
||
For transfer to Profit & Loss A/c. |
|
|
|
|
|
|
Profit & Loss A/c |
Dr. |
2,25,000 |
|
|
|
To Amortization Expense |
|
|
Cr. |
2,25,000 |
Bodie, Z., Kane, A. and Marcus, A. J. (2014) Investments. McGraw Hill
Brigham, E. and Daves, P. (2012) Intermediate Financial Management. USA: Cengage Learning.
Davies, T. and Crawford, I. (2012) Financial accounting. Harlow, England: Pearson.
Parrino, R, Kidwell, D. and Bates, T. (2012) Fundamentals of corporate finance. Hoboken, NJ: Wiley